Study using U.K. data quantifies infection risk associated with psoriasisMarch 26, 2018PsoriasisPsoriatic Arthritis
FDA approves certolizumab label update for pregnancy, breastfeedingMarch 22, 2018Psoriatic ArthritisPsoriasis
PASI responses with biologics similar among white, nonwhite individuals, study findsMarch 12, 2018PsoriasisPsoriatic Arthritis
Study highlights need to investigate psoriasis treatment outcomes in skin of color patientsMarch 9, 2018PsoriasisPsoriatic Arthritis
VIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the communityFebruary 27, 2018PsoriasisPsoriatic Arthritis
Could guselkumab be a disease-modifying agent in plaque psoriasis?February 25, 2018PsoriasisPsoriatic Arthritis
Ustekinumab quells aortic inflammation in patients with severe psoriasisFebruary 24, 2018PsoriasisPsoriatic Arthritis
Biologics have best chance of achieving PASI 90 in psoriasisFebruary 21, 2018PsoriasisPsoriatic Arthritis
